Michael Jacobsen
Director of Finance/CFO chez OMEROS CORPORATION
Fortune : 48 300 $ au 31/03/2024
Profil
Michael A.
Jacobsen is currently the Chief Accounting Officer, Treasurer & VP at Omeros Corp.
He previously worked as the Senior Director-Finance & Corporate Controller at ICOS Corp.
and as the Chief Accounting Officer & Vice President at ZymoGenetics, Inc. He also served as the Secretary, Chief Accounting Officer & VP-Finance at Sarepta Therapeutics, Inc. from 2012 to 2013.
Jacobsen received his undergraduate degree from Idaho State University in 1980.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OMEROS CORPORATION
0,02% | 22/09/2023 | 14 000 ( 0,02% ) | 48 300 $ | 31/03/2024 |
Postes actifs de Michael Jacobsen
| Sociétés | Poste | Début |
|---|---|---|
| OMEROS CORPORATION | Director of Finance/CFO | 01/08/2013 |
Anciens postes connus de Michael Jacobsen
| Sociétés | Poste | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Director of Finance/CFO | 15/11/2011 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Chief Operating Officer | 01/08/2011 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Director of Finance/CFO | - |
Formation de Michael Jacobsen
| Idaho State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| OMEROS CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
